Let's close the gap

Cell therapy holds the key to curing many chronic and life-threatening diseases. Cellerator is a state-of-the-art facility supporting multiple types of cell therapies to close the gap from technology to treatment. We believe in the future of regenerative medicine and are dedicated to developing new therapies for a healthier tomorrow.

Our vision is to be a pivotal hub in the cell therapy ecosystem, enabling transformative treatments that can cure chronic diseases.
Our mission is to facilitate the journey of cell therapies from proof of concept to clinical trials through innovation and collaboration.
Our initiative is developed and funded by the Novo Nordisk Foundation, which works to improve people’s health and the sustainability of society and the planet. The foundation is committed to advancing and applying regenerative medicine as part of its health strategy.

Cellerator is built on the values of inclusivity, sustainability and excellence. We strive to create a space where every individual feels valued and empowered to contribute to our shared mission of advancing cell therapy research and development.

Accelerating transformative treatments

Professor Mads Krogsgaard Thomsen

CEO, Novo Nordisk Foundation

"We expect this facility to become Denmark’s key link, enabling groundbreaking stem cell discoveries to reach proof-of-concept in chronic disease trials. We believe the Novo Nordisk Foundation Cellerator can be a leading player in Europe and a model globally, helping Denmark punch above its weight in the search for cures to the world’s most serious diseases."